Celltrion

Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June
Fierce Pharma
Wed, 01/29/25 - 11:20 am
Sandoz
Amgen
Celltrion
patents
biosimilars
Prolia
Xgeva
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Celltrion presents infliximab data at ECCO Congress
Clinical Trials Arena
Wed, 07/5/23 - 10:26 am
Celltrion
ECCO
infliximab
IBD
Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business
Fierce Pharma
Tue, 03/21/23 - 10:03 pm
Baxter
Thermofisher
Celltrion
M&A
CMOs
Celltrion's COVID-19 antibody improves outcomes in phase 2
Fierce Biotech
Wed, 01/13/21 - 10:48 am
Celltrion
COVID-19
antibodies
clinical trials
Corporate and regulatory developments over the holidays
EP Vantage
Mon, 01/4/21 - 10:20 am
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment
Pharmaceutical Business Review
Mon, 07/20/20 - 12:03 pm
Celltrion
COVID-19
clinical trials
antivirals
Takeda continues post-Shire selloff, inching closer to $10B goal
Endpoints
Thu, 06/11/20 - 12:16 pm
Takeda
Celltrion
M&A
Shire
South Korea
Celltrion plans July COVID-19 trial, advances 'super antibody'
Fierce Biotech
Mon, 04/13/20 - 11:02 am
Celltrion
antibodies
COVID-19
clinical trials
Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis
Pharmaceutical Business Review
Mon, 02/17/20 - 10:20 am
Celltrion
clinical trials
CT-P13
Crohn's Disease
ulcerative colitis
Celltrion plans to launch a biosimilar each year for next decade
Pharmaforum
Fri, 01/17/20 - 12:16 pm
Celltrion
South Korea
biosimilars
JPMHC 2020
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Thu, 11/7/19 - 11:05 am
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Celltrion taps Lonza to produce some of its Remicade biosimilar
Biopharma Dive
Thu, 09/5/19 - 08:19 pm
Celltrion
Lonza
Remicade
biosimilars
Remsima
Celltrion and Samsung duel shaping up as both pledge billions of dollars to biologics
Fierce Pharma
Fri, 05/17/19 - 07:28 pm
biologics
South Korea
Celltrion
Samsung Bioepis
Celltrion, iProgen Biotech join forces to develop antibody-drug conjugates
Pharmaceutical Business Review
Mon, 04/8/19 - 12:00 pm
Celltrion
iProgen Biotech
antibody-drug conjugate
FDA approves Celltrion's Herceptin biosimilar
BioCentury
Sun, 12/16/18 - 12:23 am
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
FDA approves first biosimilar for NHL
BioCentury
Thu, 11/29/18 - 12:00 am
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab
FDA panel unanimously backs Celltrion's Rituxan biosimilar
Fierce Pharma
Wed, 10/10/18 - 10:57 pm
Celltrion
Teva Pharmaceutical
biosimilars
Rituxan
FDA
advisory panels
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Tue, 10/9/18 - 12:01 pm
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels

Pages